MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Prevalence of Patient-Reported Symptoms of Dysphonia and Dysphagia in Movement Disorder Patients at an Academic Medical Center

M. Finger, M. Siddiqui, J. Tate, I. Haq, L. Madden (Winston-Salem, NC, USA)

Meeting: 2018 International Congress

Abstract Number: 1811

Keywords: Dysphagia, Dystonia: Clinical features, Parkinsonism

Session Information

Date: Monday, October 8, 2018

Session Title: Rating Scales

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: To determine the prevalence of patient-reported quality of life (QOL) measures of dysphonia and dysphagia in movement disorder patients at an academic medical center.

Background: Patient-reported symptoms of voice and swallowing impairment are thought to be common in movement disorders, namely dystonia, Parkinson’s disease (PD), atypical parkinsonisms (AP), and Essential Tremor (ET).

Methods: All patients with movement disorders referred to the movement disorders clinic were given two validated voice and swallowing specific QOL questionnaires: Voice Handicap Index – 10 (VHI-10) and Eating Assessment Tool – 10 (EAT-10). Clinical normative values were used to rate patients’ quality of life impairment.

Results: One hundred sixty-six consecutive movement disorder patients (males=98 and females=68) completed the questionnaires [(n values were PD=62, AP=21, ET=34, dystonia=17), and “other” (myoclonus=8, ataxia=8, orthostatic tremor=2, hemifacial spasm=1)]. We excluded the “other” group from analysis due to the small n values. Prevalence of patient-reported dysphonia symptoms was 32% in PD, 33% in AP, 9% in ET, and 35% in dystonia. Overall, ET patients had lower prevalence of patient-reported dysphonia symptoms when compared to PD, AP, and dystonia (p=0.0119, p=0.0454, p=0.0325, respectively). Prevalence of patient-reported dysphagia symptoms was 6% in PD, 29% in AP, 3% in ET, and 24% in dystonia. Overall, there was a significant difference between disease groups (p=0.004) with ET having lower reported dysphagia symptoms than dystonia and AP (p=0.0371, p=0.0097, respectively), and PD having lower than AP (p=0.0144).

Conclusions: In this single center cohort, patient-reported dysphonia symptoms were present in almost one third of patients with PD, AP and dystonia. AP and dystonia had a much higher prevalence of reported dysphagia symptoms than PD and ET. Patient-reported QOL measures such as VHI-10 and EAT-10 can help screen movement disorder patients for symptoms of dysphonia and dysphagia.

To cite this abstract in AMA style:

M. Finger, M. Siddiqui, J. Tate, I. Haq, L. Madden. Prevalence of Patient-Reported Symptoms of Dysphonia and Dysphagia in Movement Disorder Patients at an Academic Medical Center [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/prevalence-of-patient-reported-symptoms-of-dysphonia-and-dysphagia-in-movement-disorder-patients-at-an-academic-medical-center/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/prevalence-of-patient-reported-symptoms-of-dysphonia-and-dysphagia-in-movement-disorder-patients-at-an-academic-medical-center/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley